Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last ¥8,870 JPY
Change Today -560.00 / -5.94%
Volume 127.7K
As of 2:00 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

kobayashi pharmaceutical co (4967) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/11/15 - ¥10,770
52 Week Low
10/17/14 - ¥6,090
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for KOBAYASHI PHARMACEUTICAL CO (4967)

Related News

No related news articles were found.

kobayashi pharmaceutical co (4967) Related Businessweek News

No Related Businessweek News Found

kobayashi pharmaceutical co (4967) Details

Kobayashi Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and other products in Japan and internationally. The company offers pharmaceutical products, including obesity improving drugs, Inochi-no-Haha for women’s health promotion, and Chiku-Nain for empyema; oral hygiene products, such as Shouyou toothpaste, Tough Dent denture cleanser, Ito-Yoji dental floss, and interdental brushes; and food products comprising Tochucha supplement tea and supplements. It also provides sanitary products that consist of Keshimin for spots, Netusama Sheet cooling gel sheet, EAUDE MUGE lotion, and Aqua Moist lotion; deodorizing air fresheners, such as Bluelet toilet cleaner, PINKPINK interior air fresheners, and Shoshugen Kaoru Stick deodorant; and chemicals, including body warmers and heat relief products. In addition, the company manufactures synthetic resin products, as well as engages in the mail order sale of daily goods; and offers transportation, insurance agency, real estate management, and advertisement planning and production services. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.

2,576 Employees
Last Reported Date: 06/26/15
Founded in 1886

kobayashi pharmaceutical co (4967) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: ¥253.0M
Compensation as of Fiscal Year 2015.

kobayashi pharmaceutical co (4967) Key Developments

Kobayashi Pharmaceutical Co. Ltd. to Report Q1, 2016 Results on Jul 27, 2015

Kobayashi Pharmaceutical Co. Ltd. announced that they will report Q1, 2016 results on Jul 27, 2015

Kobayashi Pharmaceutical Co. Ltd. Reports Consolidated Earnings Results for the Year Ended March 31, 2015; Provides Earnings Guidance for the First Half and Full Year Ended March 31, 2016

Kobayashi Pharmaceutical Co. Ltd. reported consolidated earnings results for the year ended March 31, 2015. For the year, the company reported net sales of JPY 128,344 million against JPY 127,293 million a year ago. Operating income was JPY 17,917 million against JPY 18,122 million a year ago. Ordinary income was JPY 18,843 million against JPY 18,769 million a year ago. Net income was JPY 12,448 million against JPY 12,307 million a year ago. Earnings per share were JPY 305.46 against JPY 300.55 a year ago. Return on equity was 9.4% against 10.2% a year ago. Return on assets was 10.5% against 11.4% a year ago. Net cash provided by operating activities was JPY 15,445 million against JPY 13,513 million a year ago. Income before income taxes was JPY 20,056 million against JPY 19,666 million a year ago. Purchase of property, plant and equipment was JPY 3,100 million against JPY 2,885 million a year ago. Purchase of intangible assets was JPY 578 million against JPY 459 million a year ago. For the first half of 2015, the company expects net sales of JPY 61,000 million, operating income of JPY 8,200 million, ordinary income of JPY 8,200 million and net income attributable to owners of the parent of JPY 5,500 million or JPY 135.08 earnings per share. For the full year 2015, the company expects net sales of JPY 133,000 million, operating income of JPY 18,900 million, ordinary income of JPY 18,900 million and net income attributable to owners of the parent of JPY 13,000 million or JPY 319.28 earnings per share.

Kobayashi Pharmaceutical Co. Ltd., Annual General Meeting, Jun 26, 2015

Kobayashi Pharmaceutical Co. Ltd., Annual General Meeting, Jun 26, 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4967:JP ¥8,870.00 JPY -560.00

4967 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4967.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4967 Industry Range
Price/Earnings 29.9x
Price/Sales 2.9x
Price/Book 2.7x
Price/Cash Flow 28.7x
TEV/Sales 2.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KOBAYASHI PHARMACEUTICAL CO, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at